OakChart

SenesTech Inc

SNESBasic Materials·Specialty Chemicals·USA·Nano·NASD·Nov 11 • 10:05 AM ET

0.9460-0.0840 (-8.16%)
2026-11-11 16:05 CET
Market cap
5.59 USD m
Revenue, TTM
2.78 USD m
Net income, TTM
-7.66 USD m
Free cash flow, TTM
-6.66 USD m
EPS diluted, TTM
-1.44
P/E
-
Compare

Price

SNES against its 20, 50 and 200-day averages
2050200earnings
1.002.003.0029.5M59.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SNESclose 0.9520-day 0.9450-day 0.85200-day 1.440.95

73.8% under 3.61 on 10 Nov 2025. Last 15 sessions, 84.2% high to low

Profile

SNES
52-week range, 14% of the way up
0.553.40

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Surprise, AZ.

Employees24
IPODec 08, 2016
Beta0.11
ATR, 14d0.13
Rel volume0.22
Short float0.80%
Insider own4.26%
Inst own49.29%

Snapshot

6 groups

Valuation

Index-
Market Cap5.13M
Enterprise Value3.71M
Income-7.66M
Sales2.78M
Book/sh1.14
Cash/sh0.73
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees24
IPODec 08, 2016

Ratios

P/E-
Forward P/E-
PEG-
P/S1.85
P/B0.83
P/C1.30
P/FCF-
EV/EBITDA-
EV/Sales1.34
Quick Ratio3.73
Current Ratio4.51
Debt/Eq0.55
LT Debt/Eq0.50
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.44
EPS next Y-1.06
EPS next Q-0.31
EPS this Y30.77%
EPS next Y21.11%
EPS next 5Y42.02%
EPS past 3/5Y89.84% 80.37%
Sales past 3/5Y29.66% 51.10%
EPS Y/Y TTM75.01%
Sales Y/Y TTM20.86%
EPS Q/Q-29.74%
Sales Q/Q58.99%
EarningsNov 10 AMC
EPS/Sales Surpr.-15.71% 18.72%

Ownership

Insider Own4.26%
Insider Trans-
Inst Own49.29%
Inst Trans-5.66%
ROA-67.25%
ROE-96.01%
ROIC-110.78%
Gross Margin65.26%
Oper. Margin-282.38%
Profit Margin-275.26%
SMA200.85%
SMA5011.28%
SMA200-34.53%
Trades-

Technical

Shs Outstand5.42M
Shs Float5.19M
Short Float0.80%
Short Ratio0.04
Short Interest0.04M
52W High3.40 -72.18%
52W Low0.55 72.00%
Volatility10.39% 17.12%
ATR (14)0.13
RSI (14)49.64
Beta0.11
Rel Volume0.22
Avg Volume1.04M
Volume31,046

Performance

Perf Week-21.82%
Perf Month50.33%
Perf Quarter-24.62%
Perf Half Y-47.73%
Perf YTD-55.79%
Perf Year-70.39%
Perf 3Y-96.69%
Perf 5Y-99.98%
Perf 10Y-
Recom1.00
Target Price7.50
Prev Close1.03
Price0.95
Change %-8.16%

Peers

Mkt cap
TickerCompanyMkt cap
AVDAmerican Vanguard Corp24.47M
ECLEcolab Inc85.72B
BIOXBioceres Crop Solutions Corp13.69M
NEOGNeogen Corp2.55B
SMGScotts Miracle-Gro Company3.73B
ROLRollins Inc18.07B
RTORentokil Initial Plc ADR11.77B
CENTCentral Garden & Pet Co2.62B
FMCFMC Corp862.57M
SPBSpectrum Brands Holdings Inc2.03B

Insider trading

latest 14 of 44
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 28 '26Buy0.9728,00027,0232,194,973Oct 30 09:10 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 30 '26Buy1.022,0002,0332,196,973Oct 30 09:10 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 21 '26Buy0.7460,00044,3102,159,473Oct 22 06:45 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 20 '26Buy0.6736,37524,5392,099,473Oct 22 06:45 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 22 '26Buy0.807,5005,9902,166,973Oct 22 06:45 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 15 '26Buy0.77426,000327,1251,505,294Oct 19 05:38 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 19 '26Buy0.70376,552264,9422,063,098Oct 19 05:38 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerOct 16 '26Buy0.63181,252113,9891,686,546Oct 19 05:38 PM
Edell MichaelChief Executive OfficerSep 28 '26Buy0.642,0001,28911,000Sep 29 05:07 PM
Edell MichaelChief Executive OfficerSep 14 '26Buy0.841,0008409,000Sep 15 04:26 PM
Edell MichaelChief Executive OfficerSep 09 '26Buy0.872,0001,7408,000Sep 10 08:09 PM
Edell MichaelChief Executive OfficerAug 14 '26Buy1.211,0001,2106,000Aug 17 04:54 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerAug 06 '26Buy1.3015,00019,4431,072,804Aug 10 06:56 PM
GLENBROOK CAPITAL MANAGEMENT10% OwnerAug 07 '26Buy1.306,4908,4221,079,294Aug 10 06:56 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 206
  • SenesTech Crosses $1 Million In Revenue, But A Wider Loss And Fresh Dilution Keep Funding At The Center Of The Story (Earnings Whispers) -9.65% -8.16%
  • SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth (GlobeNewswire)
  • SenesTech to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026 (GlobeNewswire)
  • SenesTech Expands E-Commerce Reach Through Walmart Fulfillment Services (GlobeNewswire) +18.10%
  • SenesTech's $1.1 Million Revenue Target Puts Its E-Commerce Turnaround And Cash Runway To The Test (Earnings Whispers)
  • Loading…
  • SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding (GlobeNewswire) +15.89%
  • Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding (GlobeNewswire)
  • SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue (GlobeNewswire) +6.53%
  • GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH (PR Newswire) +8.21%
  • SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone (GlobeNewswire)
  • SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth (ACCESSWIRE) +9.25%
  • SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve Rodent Birth Control Products to Sustainability-Focused Consumers (PR Newswire)
  • SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.359-0.310-0.3611.100.922
2026Q22026-08-05-0.298-0.365-0.3450.770.602
2026Q12026-05-12-0.306-0.330-0.3920.490.631
2025Q42026-03-12-0.350-0.300-0.3450.420.781
2025Q32025-11-10-0.280-0.350-0.2780.690.701
2025Q22025-08-07-0.870--0.8710.63--
2025Q12025-05-08-1.280--1.2810.49--
2024Q42025-03-12-1.220-1.500-1.2190.500.711
2024Q32024-11-12-2.070--2.0740.48--
2024Q22024-08-08-3.080-3.200-3.0790.460.491
2024Q12024-05-09-3.600-3.400-3.5610.420.431
2023Q42024-02-21183.7-4.400-3.3720.300.381
2023Q32023-11-09-56.400-102-55.9400.360.601
2023Q22023-08-10-84.000-93.600-83.5970.310.401
2023Q12023-05-11-158.4-97.200-158.880.230.301
2022Q42023-03-16-372--3770.30-1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-18,456-42,336-18,4570.140.16
2020FY-6,672-7,896-6,6840.260.29
2021FY-1,776-1,704-1,7730.580.72
2022FY-1,860-1,992-1,8601.021.48
2023FY-115.1-302.8-115.11.191.28
2024FY-8.860-10.220-8.8601.862.06
2025FY-1.950-2.730-1.9502.222.58
2026FY--1.350--3.19
2027FY--1.065--5.24
2028FY--0.380--13.15
2029FY-0.220--21.04
2030FY-0.460--26.30

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-112101.010.861.16
2026Q4S2026-11-102101.010.861.16
2026Q4S2026-10-242101.010.861.16
2026Q4S2026-10-212201.010.861.16
2026Q4S2026-08-102200.870.860.88
2026Q4S2026-08-072100.760.650.88
2026Q4S2026-08-062000.570.500.65
2026Q4S2026-07-282000.570.500.65
2026Q4S2026-05-262010.570.500.65
2026Q4S2026-05-141010.650.650.65
2026Q4S2026-05-131000.800.800.80
2026Q4S2026-03-131000.800.800.80
2026Q4E2026-11-11210-0.31-0.32-0.30
2026Q4E2026-11-10210-0.31-0.32-0.30

Estimate history

EPS, annual-53760-30283.68-18457.44-6683.976-1773-1860.246-115.099-8.86-1.948-1.4436
Period201720182019202020212022202320242025TTM
EPS, quarterly-2.074-1.219-1.281-0.871-0.278-0.345-0.392-0.345-0.361
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0.0520.2970.1430.2820.61.0191.1931.8572.2212.78
Period201720182019202020212022202320242025TTM
Sales, quarterly0.4820.5010.4850.6250.690.4210.4930.771.097
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual000.0010.0020.0050.0070.5141.0365.2235.303
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.0131.0361.7763.7645.2235.2235.3035.303-
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2.782.221.861.191.020.600.280.140.30
Cost of Goods Sold Incl. D&A0.970.940.980.790.740.660.570.510.69
Gross Profit1.811.280.880.400.28-0.06-0.29-0.37-0.39
Selling, General and Administrative Excl. Other9.677.787.138.149.968.887.659.9211.49
Research and Development1.581.591.581.121.731.951.491.912.40
Other Operating Expense-0.000.000.000.000.000.000.000.00
Operating Income-7.85-6.50-6.25-7.73-9.67-8.93-7.93-10.29-11.88
Interest Expense-0.020.020.000.000.010.030.040.07
Unusual Expense-0.000.000.000.00-0.670.00-0.01
Net Income Before Taxes-7.66-6.38-6.18-7.71-9.70-8.27-7.94-10.02-11.91
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-7.66-6.38-6.18-7.71-9.70-8.27-7.94-10.02-12.24
Net Income From Continuing Operations-7.66-6.38-6.18-7.71-9.70-8.27-7.94-10.02-12.24
Net Income-7.66-6.38-6.18-7.71-9.70-8.27-8.37-10.03-12.24
EPS (Recurring)-1.41-1.95-8.86-115.10-1,860.25-1,874.03-6,683.97-18,457.65-30,268.16
EPS (Basic, Before Extraordinaries)-1.44-1.95-8.86-115.10-1,860.25-1,773.00-6,683.98-18,457.44-30,283.68
EPS (Diluted)-1.44-1.95-8.86-115.10-1,860.25-1,773.00-6,683.98-18,457.44-30,283.68
EBITDA-7.73-6.37-6.09-7.60-9.49-8.63-7.64-9.87-11.43
Non-Operating Income (Expense)0.210.140.090.03-0.020.000.020.310.06
Other After Tax Adjustments-0.000.000.000.000.000.000.00-0.33
Stock Option Compensation Expense0.770.260.330.560.710.770.650.873.41
Price To Sales Ratio-3.161.240.711.9018.2618.39100.3138.23
Gross Margin65.2657.4547.2333.8627.58-9.83-101.77-259.44-131.65
Operating Margin-282.38-292.89-336.51-648.11-949.36-1,489.00-2,813.12-7,193.71-4,000.00
Net Margin-275.26-287.39-333.01-646.27-951.42-1,378.00-2,969.15-7,013.29-4,121.55
Shares Outstanding-5.221.040.510.010.010.000.000.00
Market Capitalization5.595.593.420.351.895.974.407.786.87

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1.100.770.490.420.690.620.480.50
Cost of Goods Sold Incl. D&A0.330.230.180.210.280.240.200.23
Gross Profit0.760.540.310.210.410.380.280.27
Selling, General and Administrative Excl. Other2.752.402.432.091.761.991.941.53
Research and Development0.420.350.390.430.380.400.390.39
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income-1.99-1.86-2.12-1.88-1.35-1.61-1.66-1.26
Interest Expense-0.010.000.010.010.010.010.01
Unusual Expense-0.000.000.000.000.000.000.00
Net Income Before Taxes-1.96-1.83-2.06-1.80-1.30-1.62-1.67-1.25
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.96-1.83-2.06-1.80-1.30-1.62-1.67-1.25
Net Income From Continuing Operations-1.96-1.83-2.06-1.80-1.30-1.62-1.67-1.25
Net Income-1.96-1.83-2.06-1.80-1.30-1.62-1.67-1.25
EPS (Recurring)-0.36-0.35-0.39-0.35-0.28-0.87-1.28-1.22
EPS (Basic, Before Extraordinaries)-0.36-0.35-0.39-0.35-0.28-0.87-1.28-1.22
EPS (Diluted)-0.36-0.35-0.39-0.35-0.28-0.87-1.28-1.22
EBITDA-1.96-1.83-2.09-1.85-1.32-1.58-1.62-1.22
Non-Operating Income (Expense)0.040.040.060.080.060.000.000.01
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense0.520.180.020.040.050.090.090.08
Price To Sales Ratio-3.333.875.038.914.511.221.84
Gross Margin69.6469.7462.4748.9359.2860.8057.9454.29
Operating Margin-181.49-241.82-429.82-446.79-195.22-258.24-342.89-250.90
Net Margin-178.30-237.92-418.46-428.50-188.12-258.56-343.30-250.50
Shares Outstanding-5.305.305.225.223.761.781.04
Market Capitalization5.597.908.7011.1021.7010.263.163.42

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments8.571.315.394.789.333.641.944.927.12
Short Term Receivables0.200.340.100.110.080.030.150.140.02
Inventories0.990.790.800.851.000.941.181.260.54
Other Current Assets0.300.380.390.380.250.210.280.350.19
Total Current Assets10.062.816.676.1210.664.823.546.677.87
Net Property, Plant & Equipment2.750.410.600.640.841.201.441.081.45
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets---0.000.000.000.000.000.00
Other Assets0.040.060.020.020.000.000.000.000.00
Total Assets12.843.287.296.7811.506.024.987.759.32
Short Term Debt Incl. Current Port. of LT Debt0.200.060.250.180.030.100.120.220.19
Accounts Payable0.180.210.150.540.330.400.270.170.39
Other Current Liabilities0.410.290.390.600.580.291.190.770.59
Total Current Liabilities0.800.560.791.320.940.791.581.161.17
Long Term Debt2.480.210.160.180.521.340.830.260.59
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.020.04
Total Liabilities3.270.770.941.501.472.142.411.441.80
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity9.572.516.355.2810.043.882.576.317.52
Total Shareholders Equity9.572.516.355.2810.043.882.576.317.52
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity9.572.516.355.2810.043.882.576.317.52
Total Liabilities & Stockholders Equity12.843.287.296.7811.506.024.987.759.32
Book Value Per Share1.832.4212.36782.411,972.921,827.944,354.9312,912.0722,009.98
Tangible Book Value Per Share1.832.4212.36782.411,972.921,827.944,354.9312,912.0722,009.98
Full-Time Employees242325302629384439
Price to Book Ratio0.900.920.130.620.601.133.031.091.02
Return on Assets-79.19-117.00-109.56-106.05-94.37-144.30-157.35-143.36-110.72
Return on Equity-105.69-139.56-132.59-126.62-118.80-246.07-225.61-176.94-133.91
Return on Invested Capital-52.99-227.60-118.49-177.63-78.31-151.82-294.82-186.17-151.44
Quick Ratio11.363.607.483.9810.244.881.494.656.27
Current Ratio12.615.018.494.6211.306.072.245.746.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-7.66-6.38-6.18-7.71-9.70-8.27-7.94-10.02-11.91
Depreciation0.130.140.160.140.180.300.290.410.45
Other Funds (Non Cash)0.560.380.300.550.740.120.621.003.39
Funds from Operations-6.96-5.87-5.73-7.02-8.77-7.85-7.03-8.61-8.07
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital0.340.12-0.30-0.540.190.07-0.080.55-1.06
Cash from Operating Activities-6.62-5.75-6.03-7.57-8.58-7.78-7.11-8.06-9.13
Capital Expenditures-0.03-0.14-0.08-0.15-0.17-0.10-0.11-0.07-0.24
Net Assets From Acquisitions-0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.000.030.000.000.000.050.000.18
Purchase or Sale of Investments3.00-0.960.000.000.000.000.000.005.07
Purchase of Investments0.00-2.960.000.000.000.000.000.000.00
Sale Or Maturity of Investments3.002.000.000.000.000.000.000.005.07
Other Uses-0.000.000.000.000.000.000.000.00
Other Sources-0.000.000.000.000.000.000.000.00
Cash from Investing Activities2.97-1.10-0.06-0.15-0.17-0.10-0.07-0.075.02
Cash Dividends Paid-0.000.000.000.000.000.000.000.00
Change in Capital Stock0.3913.182.028.354.2313.678.375.427.34
Repurchase of Common Pref Stock-0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.3913.182.028.354.2313.678.375.427.34
Proceedsfrom Stock Options0.402.710.045.524.2312.425.743.635.13
Issuance or Reduction of Debt, Net-0.06-0.06-0.02-0.01-0.03-0.090.51-0.22-0.35
Change in Long Term Debt-0.06-0.06-0.02-0.01-0.03-0.090.51-0.22-0.35
Issuance of Long Term Debt-0.000.030.000.000.000.650.000.01
Reduction of Long Term Debt-0.06-0.06-0.04-0.01-0.03-0.09-0.14-0.22-0.36
Net Financing Active Other Cash Flow-0.000.00-0.010.00-0.020.00-0.06-0.06
Other Financing Activities Uses-0.000.00-0.010.00-0.020.00-0.06-0.06
Cash from Financing Activities0.3313.122.008.344.2013.568.885.146.93
Net Change in Cash-3.336.27-4.090.62-4.555.681.71-2.982.82
Free Cash Flow-6.66-5.89-6.12-7.71-8.75-7.88-7.22-8.13-9.37
Preferred Dividends (Cash Flow)-0.000.000.000.000.00--0.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments3.955.086.808.5710.256.05
Short Term Receivables0.250.360.160.200.450.47
Inventories0.970.971.050.990.770.71
Other Current Assets0.400.370.340.300.310.24
Total Current Assets5.566.788.3510.0611.787.47
Net Property, Plant & Equipment2.542.602.672.752.812.83
Total Investments and Advances-0.000.000.000.000.00
Other Assets0.040.040.040.040.040.06
Total Assets8.149.4211.0612.8414.6210.37
Short Term Debt Incl. Current Port. of LT Debt0.220.210.200.200.150.11
Accounts Payable0.360.310.120.180.240.12
Other Current Liabilities0.660.480.620.410.350.58
Total Current Liabilities1.231.000.940.800.750.81
Long Term Debt2.312.372.422.482.532.58
Provision for Risks Charges-0.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities3.543.373.363.273.283.39
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity4.606.057.709.5711.356.98
Total Shareholders Equity4.606.057.709.5711.356.98
Accumulated Minority Interest-0.000.000.000.000.00
Total Equity4.606.057.709.5711.356.98
Total Liabilities & Stockholders Equity8.149.4211.0612.8414.6210.37
Book Value Per Share-1.141.451.832.171.85
Tangible Book Value Per Share-1.141.451.832.171.85
Full-Time Employees---24--
Price to Book Ratio0.901.030.900.982.373.13
Return on Assets-67.25-70.73-92.33-79.19-61.18-84.00
Return on Equity-96.01-107.41-128.03-105.69-77.79-119.89
Return on Invested Capital-28.31-21.76-20.38-14.98-9.35-16.91
Quick Ratio3.735.817.7911.3614.738.35
Current Ratio4.516.788.9112.6115.759.23

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.96-1.83-2.06-1.80-1.30-1.62
Depreciation0.030.030.030.030.030.04
Other Funds (Non Cash)0.280.180.030.070.090.13
Funds from Operations-1.64-1.62-2.00-1.70-1.18-1.45
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital0.32-0.090.070.04-0.200.30
Cash from Operating Activities-1.32-1.71-1.93-1.66-1.38-1.15
Capital Expenditures-0.020.000.00-0.01-0.04-0.05
Net Assets From Acquisitions-0.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.000.000.000.000.00
Purchase or Sale of Investments0.000.001.002.00-2.960.00
Purchase of Investments0.000.000.000.00-2.960.00
Sale Or Maturity of Investments0.000.001.002.000.000.00
Other Uses-0.000.000.000.000.00
Other Sources-0.000.000.000.000.00
Cash from Investing Activities-0.020.001.001.99-3.01-0.05
Cash Dividends Paid-0.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock0.230.000.17-0.015.625.61
Repurchase of Common Pref Stock-0.000.000.000.000.00
Sale of Common Pref Stock0.230.000.17-0.015.625.61
Proceedsfrom Stock Options0.230.000.170.000.001.64
Issuance or Reduction of Debt, Net-0.02-0.01-0.01-0.01-0.01-0.01
Change in Long Term Debt-0.02-0.01-0.01-0.01-0.01-0.01
Issuance of Long Term Debt-0.000.000.000.000.00
Reduction of Long Term Debt-0.02-0.01-0.01-0.01-0.01-0.01
Net Financing Active Other Cash Flow-0.000.000.000.000.00
Other Financing Activities Uses-0.000.000.000.000.00
Cash from Financing Activities0.21-0.010.16-0.035.615.60
Net Change in Cash-0.13-1.72-1.770.301.224.40
Free Cash Flow-1.34-1.71-1.93-1.68-1.42-1.20

Revenue breakdown

Total Agricultural Chemicals revenue2024: 1.86M 2025: 2.22M
United States2024: 1.86M 2025: 2.22M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.80%0.0M5.2M1.06M
2026-10-150.60%0.0M5.2M991.79K
2026-09-300.53%0.0M5.2M85.68K
2026-09-150.59%0.0M5.2M84.46K
2026-08-310.78%0.0M5.2M80.65K
2026-08-141.02%0.1M5.2M83.41K
2026-07-311.35%0.1M5.2M80.95K
2026-07-150.54%0.0M5.1M77.22K
2026-06-301.08%0.1M5.1M69.35K
2026-06-151.32%0.1M5.1M69.76K
2026-05-291.10%0.1M5.1M74.15K
2026-05-151.82%0.1M5.1M76.11K
2026-04-300.47%0.0M5.1M49.24K
2026-04-150.61%0.0M5.1M53.47K
2026-03-310.38%0.0M5.1M53.45K
2026-03-130.55%0.0M5.1M58.52K
2026-02-270.99%0.0M5.0M51.94K
2026-02-130.44%0.0M5.0M53.21K
2026-01-300.73%0.0M5.0M57.73K
2026-01-150.26%0.0M5.0M59.21K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-10-30SCHEDULE 13GSEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-30SCHEDULE 13D/ASEC
2026-10-26SCHEDULE 13DSEC
2026-10-228-KCurrent report2026-10-20SEC
2026-10-224Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-10-22SCHEDULE 13D/ASEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-19SCHEDULE 13D/ASEC
2026-10-158-KCurrent report2026-10-15SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-08-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-23SCHEDULE 13DSEC
2026-07-224Statement of changes in beneficial ownership of securities2026-07-20SEC
2026-07-084Statement of changes in beneficial ownership of securities2026-07-07SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10809.95K800
2026-093.87K300
2026-0829.08K300
2026-0753.00K200
2026-06113.38K700
2026-0558.50K500
2026-044.41K100
2026-03330.18K300
2026-02357.20K900
2026-0110.11K100
2025-120000
2025-11001712

Institutional holders

Manager% owned
SABBY MANAGEMENT, LLC2.67%
RENAISSANCE TECHNOLOGIES LLC1.56%
GEODE CAPITAL MANAGEMENT, LLC0.89%
CITADEL ADVISORS LLC0.88%
VANGUARD CAPITAL MANAGEMENT LLC0.66%
VANGUARD FIDUCIARY TRUST CO0.50%
ESSEX INVESTMENT MANAGEMENT CO LLC0.48%
DIVERSIFY WEALTH MANAGEMENT, LLC0.35%
Diversify Advisory Services, LLC0.35%
NORTHERN TRUST CORP0.33%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.67%
VANGUARD EXTENDED MARKET INDEX FUND0.66%
Fidelity Series Total Market Index Fund0.13%
Fidelity Total Market Index Fund0.02%
State Street Balanced Index Fund0.01%

OakChart. SNES. Cached 15 minutes.

Some panels did not load: ratings.